A Study on Rheumatoid Arthritis Patients Treated With Rituximab

The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rheumatoid Arthritis Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Immune System Diseases Joint Diseases Musculoskeletal Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Helsinki, Finland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Rheumatoid arthritis (RA) patients treated with rituximab in Finland

Exclusion criteria

Not applicable

Treatment and study plan

Rituximab

Drug

This is an observational study. Patients with rheumatoid arthritis and having received treatment previously will be assessed for the treatment responses.

Primary outcomes

Information on previous RA treatments

Time frame: 3 months
Information on rituximab treatment responses

Time frame: 3 months
Information on concomitant medications

Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Retrospective Data Collection on Rheumatoid Arthritis (RA) Patients Treated With Rituximab in Finland.

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Dec 4, 2015
Registry last updated: Dec 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed